About SonarMD
SonarMD is a private company based in Chicago, Illinois. It has reported $10,499,309 raised in four offerings on Form D since May 2023. Its chief executive is Beth Houck.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Mar 4, 2026 | $2,999,999of $6.9M target | 1 | $2.9M | EquityRule 506(b) | Form D ↗ |
| Dec 24, 2024 | Jan 6, 2025 | $2,154,581of $3.0M target | 3 | $718K | EquityRule 506(b) | Form D ↗ |
| Jul 16, 2024 | Jul 17, 2024 | $1,000,000of $2.0M target | 1 | $1.0M | DebtRule 506(b) | Form D ↗ |
| Apr 10, 2023 | May 16, 2023 | $4,344,729fully sold | 3 | $1.4M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $10,499,309 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on SonarMD's Form D filed Mar 4, 2026.
Earlier filings also listed Thomas Shehab (director, last listed Jul 2024), Emir Sandhu (director, last listed May 2023), John Starr (executive officer, last listed Feb 2020), Devin Gross (chief executive officer and director, last listed Feb 2020) and Anna Haghgooie (director, last listed Feb 2020).
Sources
- SECSONARMD, INC. filing history
- CompanyAbout SonarMD
- CompanyPrivacy policy